miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma
Authors:
Open Access
- 1 September 2011
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 124 (17) , 2997-3005
Abstract
MicroRNAs (miRNAs) are small noncoding RNAs that are involved in various diseases, including cancer. In the present study, we found that miR-216b was downregulated in nasopharyngeal carcinoma (NPC) cell lines and specimens. Decreased expression of miR-216b was directly related to advanced clinical stage and lymph node metastasis. miR-216b levels correlated inversely with levels of KRAS protein during nasopharyngeal tumorigenesis. Furthermore, we demonstrated that miR-216b can bind to the 3′ untranslated region (UTR) of KRAS and inhibit expression of the KRAS protein. Both in vitro and in vivo assays revealed that miR-216b attenuated NPC cell proliferation, invasion and tumor growth in nude mice. miR-216b exerts its tumor suppressor function through inhibition of the KRAS-related AKT and ERK pathways. Our findings provide, for the first time, significant clues regarding the role of miR-216b as a tumor suppressor by targeting KRAS in NPC.Keywords
This publication has 34 references indexed in Scilit:
- The Ras‐ERK pathway: Understanding site‐specific signaling provides hope of new anti‐tumor therapiesBioEssays, 2010
- K-Ras Promotes Growth Transformation and Invasion of Immortalized Human Pancreatic Cells by Raf and Phosphatidylinositol 3-Kinase SignalingCancer Research, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- Specificity of microRNA target selection in translational repressionGenes & Development, 2004
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- A common region of allelic loss on chromosome region 3p25.3–26.3 in nasopharyngeal carcinomaGenes, Chromosomes and Cancer, 1998
- Role of proto-oncogene activation in carcinogenesis.Environmental Health Perspectives, 1992
- Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma.Proceedings of the National Academy of Sciences, 1989
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesCell, 1988